This topic contains a solution. Click here to go to the answer

Author Question: If a firm's short-run average cost curves are u-shaped, does this imply that the long-run average ... (Read 123 times)

BrownTown3

  • Hero Member
  • *****
  • Posts: 564
If a firm's short-run average cost curves are u-shaped, does this imply that the long-run average cost curve must also be u-shaped?
 
  What will be an ideal response?

Question 2

Refer to Scenario 1-2. Using marginal analysis terminology, another economic term for the incremental cost of producing the last 300 hats is
 
  A) marginal cost. B) explicit cost.
  C) operating cost. D) Any of the above terms are correct.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Sierray

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

No. The short-run average cost curves are u-shaped because of gains from division of labor in the beginning and then diminishing returns due to the fixed scale of production in the short run. In the long run, the firm is able to change its scale of production so no diminishing returns occur. Thus, the shape of the long-run average cost curve depends on whether the firm faces increasing, constant, or decreasing returns to scale.

Answer to Question 2

A




BrownTown3

  • Member
  • Posts: 564
Reply 2 on: Jun 29, 2018
Wow, this really help


samiel-sayed

  • Member
  • Posts: 337
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

Did you know?

Serum cholesterol testing in adults is recommended every 1 to 5 years. People with diabetes and a family history of high cholesterol should be tested even more frequently.

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library